Medical Monitoring Plan Introduced in C8 Environmental Tort Litigation
According to a recent report, a panel of doctors has released recommended protocols for medical monitoring of Ohio and West Virginia residents exposed to the toxic chemical, C8. The medical panel’s plan addresses procedures for initial screening and diagnostic testing, as well as the need for future modification. The medical panel’s plan also suggests educational materials to inform residents about the risks and benefits of screening.
The medical monitoring program is the result of findings released in October 2012 by the C8 Science Panel. In particular, the C8 Science Panel reported several probable links between C8 exposure and human illness, including high cholesterol, kidney cancer, thyroid disease, testicular cancer, ulcerative colitis, and pregnancy-induced hypertension. The findings stemmed from a series of studies, which examined approximately 70,000 residents from the affected area, including DuPont employees.
For nearly half a century, DuPont used C8 at its Washington Works Plant in Parkersburg, West Virginia to manufacture Teflon and other products. Plaintiffs allege that the widespread contamination was caused by DuPont’s manufacturing process releasing significant amounts of C8 into the air and water surrounding the plant, and the chemical being disposed of in nearby landfills and the Ohio River – resulting in C8 contamination across six water districts in the mid-Ohio Valley.
Roger C. Denton has been appointed to the Plaintiffs’ Steering Committee in the E.I. DuPont De Nemours and Company C8 Personal Injury Litigation, MDL No. 2433, pending in the United States District Court for the Southern District of Ohio. Presently, there are 44 lawsuits pending in the MDL.
Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements.